Bone tumor final

sudarshan731 1,130 views 45 slides Mar 21, 2020
Slide 1
Slide 1 of 45
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45

About This Presentation

Bone tumor Overview


Slide Content

Bone Tumors Dr. Sudarshan Pandey First year Resident Department of Orthopaedics and Traumatology

Epidemiology Bone and soft tissue sarcoma – derived from mesenchymal origin Bone sarcoma – 0.2% Male > Female Age – male >85 years , female- 50-60 years

Epidemiology

Classification Benign lesion Non ossifying fibroma Aneurysmal bone cyst Intermediate (locally aggressive) lesion Osteoblastoma

Classifications Intermediate (rarely metastasizing) lesion Risk of spread < 2% , often non fatal Giant cell tumor of bone Malignant tumors Aggressiveness defined by histological grade Low grade tumor- metastatic rate: 2-10% chordoma, parosteal osteosarcoma High grade tumor – metastatic rate : 20- 100 % Osteosarcoma, Ewing's sarcoma

World Health Organization (WHO) histological classification of tumours

Field theory of bone tumors

General approach History- patient information, Pain , Mass Examination Investigation Imaging ( X rays , CT , MRI , Radionuclide scanning) Systemic evaluation ( in case of secondaries ) PSA, Bence - Jones protein, Serum Calcium, ALP ESR , CRP Biopsy – gold standard

Clinical Presentation Asymptomatic Pain Swelling/mass All superficial soft tissue lesions measuring >5cm and all deep seated lesions should be considered a sarcoma until proven otherwise Pathological fractures Systemic findings

Investigations X-Rays

Epiphyseal Lesions Chondroblastoma (ages 10-25) Giant cell tumor (ages 20-40) Clear chondrosarcoma (rare) 15y/M 25y/M

Ewing sarcoma (ages 5-25) Lymphoma (adult) Fibrous dysplasia (ages 5-30) Adamantinoma (consider in the tibia) Histiocytosis (ages 5-30) Diaphyseal Lesions

Location in Bone Axial Central – Enchondroma , Unicameral Bone Cyst Conventional osteosarcoma Ewing sarcoma Myeloma, lymphoma Eccentric- Aneurysmal bone cyst(ABC) GCT, Non Ossifying fibroma(NOF) Eosinophilic granuloma Enchondroma , fibrous dysplasia

Cortical Cortical osteoid osteoma Fibrous cortical defect Adamantinoma Osteofibrous dysplasia Pagets disease Juxtacortical Parosteal chondroma Surface osteosarcoma Osteochondroma Exostotic chondrosarcoma Surface osteosarcoma

Radiographic features Lesion margin Periosteal reaction Mineralized matrix

Lodwick classification of lytic bone lesions Low biological activity/aggressiveness High biological activity / aggresiveness

Perisoteal reaction Non aggressive Continuous / solid Aggressive codman’s triangle Sun burst appearance / spiculated /hair on end Lamellated Benign Aggressive

Mineralized matrix Osteoid Chondroid Fibrous

Lesions of the Spine Older than 40 Years Metastases Vertebral body, pelvis Proximal femur, proximal humerus skull Multiple myeloma Hemangioma Chordoma (in sacrum) Younger than 30 Years Vertebral body Histiocytosis Hemangioma Posterior elements Osteoid osteoma Osteoblastoma Aneurysmal bone cyst

Multiple Lesions Histiocytosis Enchondroma Osteochondroma Fibrous dysplasia Multiple myeloma Metastases Hemangioma Infection Hyperparathyroidism

Sclerotic metastasis Prostatic Ca Breast Ca Transitional Cell Ca Carcinoid Mucinous Adeno Ca Lytic bone metastasis Lung Ca Renal Cell Ca Thyroid Ca Adrenal gland Ca Uterine Ca Melanoma

Computed tomography Shows accurately intraosseous and extraosseous extension Great for cortical bone evaluation Helps in staging MRI Defines local extent of lesion , tissue characterization Useful in assessing soft tissue tumor and cartilaginous tumor Radionuclide scanning 99mTcMDP – non specific reactive changes – reveal site of small tumor (osteoid osteoma) Detecting skip lesions , evidence of metastatic disease

Definition of histopathological parameters in the Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grading system (HPF = high-power field)

Enneking staging system Based on: Tumor grade Metastasis Confinement in compartment A compartment, for the purposes of this system, is defined as an enclosed tissue space, such as a bone, a joint space or a muscle group confined by its fascial envelope

Enneking staging system Malignant Stage Grade Site Metastasis IA Low Grade Intra- compartmental No metastasis IB Low Grade Extra- compartmental No metastasis IIA High Grade Intra- compartmental No metastasis IIB High Grade Extra- compartmental No metastasis III Any Any Metastases Benign Latent—low biologic activity; well marginated ; often incidental findings (i.e., nonossifying fibroma) Active—symptomatic ; limited bone destruction; may present with pathologic fracture (i.e., aneurysmal bone cyst) Aggressive—aggressive; bone destruction/soft-tissue extension(i.e ., giant cell tumor)

TNM staging Definition of regional lymph node (N)

TNM staging Spine Pelvis

TNM stages Stage 1A Low-grade , small, no metastases Stage 1B Low-grade , large, no metastases Stage 2A Intermediate- or high- grade , small, no metastases Stage 2B Intermediate-grade , large, no metastases Stage 3 High-grade , large, no metastases Stage 4 Any with metastases

AJCC System

Biopsy-Principles R eferred to the institution where definitive treatment will take place . Should be done after clinical, lab and radiographic examinations Planned placement of biopsy incision biopsy track should be considered contaminated with tumor cells biopsy track needs to be excised en bloc with the tumor The surgeon performing the biopsy should be familiar with incisions for limb salvage surgery and standard and nonstandard amputation flaps

Biopsy- Principles If a tourniquet is used, the limb elevated before inflation but should not be exsanguinated by compression to prevent “squeezing” the tumor’s cells into the systemic circulation Transverse incisions should be avoided The deep incision should go through single muscle compartment Avoid major neurovascular structure Soft tissue extension of bone lesion should be sampled

Biopsy- Principles hole in the bone should be round or oval Frozen section should be sent intraoperatively to ensure that diagnostic tissue has been obtained meticulous hemostasis ensured before closure Drain should exit in line with the incision Wound should be closed tightly in layers

Biopsy- Principles Sample should be sent for microbiology as well as histology The pathologist reporting biopsy must have an appropriate level of experience If risk of fracture following biopsy, bone must be splinted

Types of Biopsy

Bone tumor Mimics Soft tissue hematoma Myositis Ossificans Stress fractures Tendon avulsion injuries Infection Osteopetrosis Osteopoikilosis Melorheostosis - dripping candle wax

Management Primary Goal with primary malignancy- make patient disease free Goal of treatment of patient with metastatic carcinoma to bone: Minimize pain Preserve function Optimal treatment of tumor : Surgery Radiation therapy Chemotherapy

Radiation therapy Blue cell tumor Multiple myeloma Lymphoma Ewings sarcoma Secondaries (Except – RCC) Reduce local recurrence of malignant soft tissue tumor

Chemotherapy Adjuvant Neoadjuvant Osteosarcoma Malignant fibrous histiocytoma Rhabdomyosarcoma Not useful in cartilaginous lesion

Principles of Surgery Amputation vs Limb salvage Survival? Morbidity ? Salvaged limb vs prosthesis Psychosocial conseuences

References Campbell’s Operative Orthopaedics -13 th edition Apley and Solomon’s System of Orthopaedics and Trauma -10 th edition Millers Review of Orthopedics- 7 th edition

Thank you
Tags